Canada Filament Health to supply psilocybin for federally-funded psychedelics clinical trial The trial is the first psilocybin study funded by the Canadian Institutes of Health Research (CIHR) Natalia Buendia CalvilloNovember 17, 2022
International Enosis and OVID Clinics offer VR-modulated psychedelic therapy in Berlin The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy Rowan DunneNovember 3, 2022
Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Canada Spirit Plant Medicine Conference returns at UBC to discuss psychedelics and consciousness 11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from Florida Rowan DunneOctober 28, 2022
Psychedelics Small Pharma acquires U.S. patent for its DMT compounds The company has enhanced its IP portfolio with a patent that will be valid until 2041 Rowan DunneOctober 21, 2022
Business Pot firm HYTN receives license to produce and sell psilocybin HYTN can possess up to 300gr of psilocybin and sell it in other countries Natalia Buendia CalvilloOctober 17, 2022
Psychedelics People are taking large doses of psychedelics to treat pain: survey study Although the effects were weaker and more prone to bias, microdoses also seemed to be efficient in pain management Natalia Buendia CalvilloOctober 6, 2022
Research ‘Endogenous’ DMT plays an important role in animal physiology: study review DMT is the backbone structure of popular psychedelics being tested for medical purposes such as psilocin and LSD Natalia Buendia CalvilloOctober 3, 2022
Business Optimi enters psilocybin supply agreement to open healthcare centre in Costa Rica The psilocybin producer will be working with the Knowde Group, Inc., BC Green Pharmaceuticals Inc. and Promises Innovative Recovery (PIR) Natalia Buendia CalvilloAugust 30, 2022
Business Numinus reports sequential revenue dip of 5.7% The drop was due to a shift in Numinus Bioscience operations Natalia Buendia CalvilloJuly 15, 2022